CN105707707A - 藜麦孕产妇超级营养粉 - Google Patents
藜麦孕产妇超级营养粉 Download PDFInfo
- Publication number
- CN105707707A CN105707707A CN201610180050.1A CN201610180050A CN105707707A CN 105707707 A CN105707707 A CN 105707707A CN 201610180050 A CN201610180050 A CN 201610180050A CN 105707707 A CN105707707 A CN 105707707A
- Authority
- CN
- China
- Prior art keywords
- quinoa
- pregnant
- super
- women
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 240000006162 Chenopodium quinoa Species 0.000 title claims abstract description 56
- 239000000843 powder Substances 0.000 title claims abstract description 38
- 235000016709 nutrition Nutrition 0.000 title abstract description 26
- 230000035764 nutrition Effects 0.000 title abstract description 19
- 210000000582 semen Anatomy 0.000 claims abstract description 65
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims abstract description 64
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims abstract description 32
- 229960004488 linolenic acid Drugs 0.000 claims abstract description 32
- 244000062793 Sorghum vulgare Species 0.000 claims abstract description 9
- 235000019713 millet Nutrition 0.000 claims abstract description 9
- 240000001417 Vigna umbellata Species 0.000 claims abstract description 7
- 235000011453 Vigna umbellata Nutrition 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims description 17
- 230000000050 nutritive effect Effects 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 6
- 238000005516 engineering process Methods 0.000 claims description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims 1
- 238000009700 powder processing Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 58
- 208000007502 anemia Diseases 0.000 abstract description 33
- 239000008280 blood Substances 0.000 abstract description 26
- 210000004369 blood Anatomy 0.000 abstract description 25
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 21
- 201000010099 disease Diseases 0.000 abstract description 20
- 235000013305 food Nutrition 0.000 abstract description 16
- 210000003734 kidney Anatomy 0.000 abstract description 14
- 230000036039 immunity Effects 0.000 abstract description 13
- 238000011161 development Methods 0.000 abstract description 12
- 230000018109 developmental process Effects 0.000 abstract description 12
- 210000000952 spleen Anatomy 0.000 abstract description 12
- 241000196324 Embryophyta Species 0.000 abstract description 9
- 201000006549 dyspepsia Diseases 0.000 abstract description 9
- 235000013336 milk Nutrition 0.000 abstract description 9
- 239000008267 milk Substances 0.000 abstract description 9
- 210000004080 milk Anatomy 0.000 abstract description 9
- 210000002784 stomach Anatomy 0.000 abstract description 9
- 208000004880 Polyuria Diseases 0.000 abstract description 8
- 230000035619 diuresis Effects 0.000 abstract description 8
- 230000002124 endocrine Effects 0.000 abstract description 7
- 235000013312 flour Nutrition 0.000 abstract description 7
- 206010006187 Breast cancer Diseases 0.000 abstract description 6
- 208000026310 Breast neoplasm Diseases 0.000 abstract description 6
- 230000012010 growth Effects 0.000 abstract description 6
- 238000005728 strengthening Methods 0.000 abstract description 6
- 230000002936 tranquilizing effect Effects 0.000 abstract description 5
- 208000002720 Malnutrition Diseases 0.000 abstract description 4
- 206010067171 Regurgitation Diseases 0.000 abstract description 4
- 206010047700 Vomiting Diseases 0.000 abstract description 4
- 230000004596 appetite loss Effects 0.000 abstract description 4
- 230000002950 deficient Effects 0.000 abstract description 4
- 210000003127 knee Anatomy 0.000 abstract description 4
- 208000019017 loss of appetite Diseases 0.000 abstract description 4
- 235000021266 loss of appetite Nutrition 0.000 abstract description 4
- 230000001071 malnutrition Effects 0.000 abstract description 4
- 235000000824 malnutrition Nutrition 0.000 abstract description 4
- 208000015380 nutritional deficiency disease Diseases 0.000 abstract description 4
- 230000001737 promoting effect Effects 0.000 abstract description 4
- 230000008439 repair process Effects 0.000 abstract description 4
- 230000003796 beauty Effects 0.000 abstract description 3
- 230000007812 deficiency Effects 0.000 abstract description 3
- 230000035922 thirst Effects 0.000 abstract description 3
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 abstract description 2
- 235000017647 Brassica oleracea var italica Nutrition 0.000 abstract description 2
- 240000003259 Brassica oleracea var. botrytis Species 0.000 abstract description 2
- 235000012041 food component Nutrition 0.000 abstract description 2
- 230000001939 inductive effect Effects 0.000 abstract description 2
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 abstract 1
- 208000002495 Uterine Neoplasms Diseases 0.000 abstract 1
- 208000031971 Yin Deficiency Diseases 0.000 abstract 1
- 238000011109 contamination Methods 0.000 abstract 1
- 206010061428 decreased appetite Diseases 0.000 abstract 1
- 235000001497 healthy food Nutrition 0.000 abstract 1
- 230000006651 lactation Effects 0.000 abstract 1
- 230000002040 relaxant effect Effects 0.000 abstract 1
- 230000009758 senescence Effects 0.000 abstract 1
- 206010046766 uterine cancer Diseases 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 29
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 22
- 108090000623 proteins and genes Proteins 0.000 description 22
- 235000015097 nutrients Nutrition 0.000 description 19
- 230000035935 pregnancy Effects 0.000 description 19
- 235000018102 proteins Nutrition 0.000 description 19
- 102000004169 proteins and genes Human genes 0.000 description 19
- 238000011160 research Methods 0.000 description 19
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 18
- 239000011575 calcium Substances 0.000 description 18
- 229910052791 calcium Inorganic materials 0.000 description 18
- 235000001465 calcium Nutrition 0.000 description 18
- 210000004027 cell Anatomy 0.000 description 18
- 210000004958 brain cell Anatomy 0.000 description 17
- 239000003925 fat Substances 0.000 description 16
- 235000019197 fats Nutrition 0.000 description 16
- 210000003754 fetus Anatomy 0.000 description 16
- 239000000047 product Substances 0.000 description 15
- 210000004556 brain Anatomy 0.000 description 14
- 239000000203 mixture Substances 0.000 description 14
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 13
- 230000032683 aging Effects 0.000 description 12
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 11
- 206010028980 Neoplasm Diseases 0.000 description 11
- 201000011510 cancer Diseases 0.000 description 11
- 230000002708 enhancing effect Effects 0.000 description 11
- 229960000304 folic acid Drugs 0.000 description 11
- 235000019152 folic acid Nutrition 0.000 description 11
- 239000011724 folic acid Substances 0.000 description 11
- 230000006870 function Effects 0.000 description 11
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 10
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 10
- 229910052500 inorganic mineral Inorganic materials 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 10
- 239000000463 material Substances 0.000 description 10
- 239000011707 mineral Substances 0.000 description 10
- 235000010755 mineral Nutrition 0.000 description 10
- 235000001014 amino acid Nutrition 0.000 description 9
- 150000001413 amino acids Chemical class 0.000 description 9
- 230000033228 biological regulation Effects 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 9
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 9
- 206010010774 Constipation Diseases 0.000 description 8
- 235000013325 dietary fiber Nutrition 0.000 description 8
- 230000004438 eyesight Effects 0.000 description 8
- 239000000194 fatty acid Substances 0.000 description 8
- 239000007952 growth promoter Substances 0.000 description 8
- 230000036541 health Effects 0.000 description 8
- 230000036737 immune function Effects 0.000 description 8
- 230000035790 physiological processes and functions Effects 0.000 description 8
- 230000002265 prevention Effects 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 7
- 239000013589 supplement Substances 0.000 description 7
- 229930003427 Vitamin E Natural products 0.000 description 6
- 230000004641 brain development Effects 0.000 description 6
- 235000013339 cereals Nutrition 0.000 description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 6
- 238000002372 labelling Methods 0.000 description 6
- 230000004060 metabolic process Effects 0.000 description 6
- 230000002633 protecting effect Effects 0.000 description 6
- 235000019165 vitamin E Nutrition 0.000 description 6
- 239000011709 vitamin E Substances 0.000 description 6
- 229940046009 vitamin E Drugs 0.000 description 6
- 208000003351 Melanosis Diseases 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 5
- 240000007594 Oryza sativa Species 0.000 description 5
- 235000007164 Oryza sativa Nutrition 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 230000001605 fetal effect Effects 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 235000009566 rice Nutrition 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 239000011701 zinc Substances 0.000 description 5
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 description 4
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 230000004663 cell proliferation Effects 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 230000002526 effect on cardiovascular system Effects 0.000 description 4
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 230000004578 fetal growth Effects 0.000 description 4
- 235000013350 formula milk Nutrition 0.000 description 4
- 230000001983 lactogenic effect Effects 0.000 description 4
- 229910052748 manganese Inorganic materials 0.000 description 4
- 239000011572 manganese Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000004224 protection Effects 0.000 description 4
- VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 description 4
- 230000001629 suppression Effects 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- 230000008673 vomiting Effects 0.000 description 4
- 229910052725 zinc Inorganic materials 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 206010008570 Chloasma Diseases 0.000 description 3
- 208000017667 Chronic Disease Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- 208000006399 Premature Obstetric Labor Diseases 0.000 description 3
- 206010036600 Premature labour Diseases 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 210000001789 adipocyte Anatomy 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 208000003464 asthenopia Diseases 0.000 description 3
- 230000000711 cancerogenic effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- 210000004209 hair Anatomy 0.000 description 3
- 210000000987 immune system Anatomy 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 235000020778 linoleic acid Nutrition 0.000 description 3
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 235000014786 phosphorus Nutrition 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 208000026440 premature labor Diseases 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 108091035539 telomere Proteins 0.000 description 3
- 210000003411 telomere Anatomy 0.000 description 3
- 102000055501 telomere Human genes 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 208000012991 uterine carcinoma Diseases 0.000 description 3
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 208000032170 Congenital Abnormalities Diseases 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 206010014198 Eczema infantile Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 208000001362 Fetal Growth Retardation Diseases 0.000 description 2
- 206010070531 Foetal growth restriction Diseases 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 208000018525 Postpartum Hemorrhage Diseases 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 240000005498 Setaria italica Species 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 235000021407 appetite control Nutrition 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 201000008937 atopic dermatitis Diseases 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 201000008275 breast carcinoma Diseases 0.000 description 2
- 231100000357 carcinogen Toxicity 0.000 description 2
- 239000003183 carcinogenic agent Substances 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 235000005686 eating Nutrition 0.000 description 2
- 235000004626 essential fatty acids Nutrition 0.000 description 2
- 229940011871 estrogen Drugs 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000035558 fertility Effects 0.000 description 2
- 208000030941 fetal growth restriction Diseases 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 230000002607 hemopoietic effect Effects 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- IVYPNXXAYMYVSP-UHFFFAOYSA-N indole-3-methanol Chemical compound C1=CC=C2C(CO)=CNC2=C1 IVYPNXXAYMYVSP-UHFFFAOYSA-N 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 208000017169 kidney disease Diseases 0.000 description 2
- 230000037356 lipid metabolism Effects 0.000 description 2
- 238000005461 lubrication Methods 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 230000037323 metabolic rate Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000009984 peri-natal effect Effects 0.000 description 2
- 235000021395 porridge Nutrition 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000004223 radioprotective effect Effects 0.000 description 2
- 230000004491 retinal development Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 208000002254 stillbirth Diseases 0.000 description 2
- 231100000537 stillbirth Toxicity 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 210000000225 synapse Anatomy 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- CFWRDBDJAOHXSH-SECBINFHSA-N 2-azaniumylethyl [(2r)-2,3-diacetyloxypropyl] phosphate Chemical compound CC(=O)OC[C@@H](OC(C)=O)COP(O)(=O)OCCN CFWRDBDJAOHXSH-SECBINFHSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010049865 Achromotrichia acquired Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000037259 Amyloid Plaque Diseases 0.000 description 1
- 206010002065 Anaemia megaloblastic Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- 241000219193 Brassicaceae Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 235000015493 Chenopodium quinoa Nutrition 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 208000015943 Coeliac disease Diseases 0.000 description 1
- 208000027205 Congenital disease Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 206010013486 Distractibility Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010016880 Folate deficiency Diseases 0.000 description 1
- 208000010188 Folic Acid Deficiency Diseases 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical class C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 102000004889 Interleukin-6 Human genes 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 206010022971 Iron Deficiencies Diseases 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 208000019395 Lactation disease Diseases 0.000 description 1
- 241000208204 Linum Species 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 208000000682 Megaloblastic Anemia Diseases 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 208000005736 Nervous System Malformations Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 241000567232 Ochnaceae Species 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 241000283898 Ovis Species 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 208000001300 Perinatal Death Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QKGJFQMGPDVOQE-UHFFFAOYSA-N Sulforaphen Natural products CS(=O)C=CCCN=C=S QKGJFQMGPDVOQE-UHFFFAOYSA-N 0.000 description 1
- 206010042576 Suppressed lactation Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- -1 VitAVitE Substances 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 206010048222 Xerosis Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001062 anti-nausea Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000022534 cell killing Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000009087 cell motility Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000008133 cognitive development Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- DVSZKTAMJJTWFG-UHFFFAOYSA-N docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCCC=CC=CC=CC=CC=CC=CC(O)=O DVSZKTAMJJTWFG-UHFFFAOYSA-N 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000000517 effect on sleep Effects 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000008175 fetal development Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000031169 hemorrhagic disease Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000003832 immune regulation Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 235000002279 indole-3-carbinol Nutrition 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229940100601 interleukin-6 Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000010226 intestinal metabolism Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 231100001016 megaloblastic anemia Toxicity 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 230000004066 metabolic change Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 230000001483 mobilizing effect Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 230000030363 nerve development Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 239000002664 nootropic agent Substances 0.000 description 1
- 230000001777 nootropic effect Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 230000019240 optic nerve development Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000008557 oxygen metabolism Effects 0.000 description 1
- 235000002252 panizo Nutrition 0.000 description 1
- 230000003950 pathogenic mechanism Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 229940067631 phospholipid Drugs 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 235000021085 polyunsaturated fats Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 201000011461 pre-eclampsia Diseases 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 210000004129 prosencephalon Anatomy 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- QKGJFQMGPDVOQE-HWKANZROSA-N raphanin Chemical compound CS(=O)\C=C\CCN=C=S QKGJFQMGPDVOQE-HWKANZROSA-N 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 235000021003 saturated fats Nutrition 0.000 description 1
- 201000000980 schizophrenia Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 230000008470 skin growth Effects 0.000 description 1
- 230000009576 somatic growth Effects 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
- 230000001550 time effect Effects 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 235000003563 vegetarian diet Nutrition 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- DTOSIQBPPRVQHS-UHFFFAOYSA-N α-Linolenic acid Chemical compound CCC=CCC=CCC=CCCCCCCCC(O)=O DTOSIQBPPRVQHS-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
藜麦孕产妇超级营养粉属于健康食品或保健食品,尤以青藏高原天然无污染优质药食两用植物藜麦粉(藜麦芽粉)、黑芝麻粉、小米粉、红豆粉、α?亚麻酸、西兰花为原料,该产品含有全面的天然植物营养成分,具有滋阴养肾、健脾和胃、清虚热、养心安神、除湿利尿、通乳泌乳,可治孕产妇脾肾阴虚、消化不良、反胃呕吐、营养不良、腰膝酸软、产后气血不足、奶水稀少、贫血、口渴、食少纳呆、吃不下饭、修复体质。另外还具有增强免疫力、调节内分泌、促进儿童生长发育、预防疾病、美容养颜、减肥、通便、延缓衰老、预防乳腺癌和子宫癌等功效,也是孕产妇的超级营养食品。
Description
一、技术领域:本发明属于健康食品或功能食品,尤以青藏高原天然无污优质药食两用植物藜麦粉(藜麦芽粉)、黑芝麻粉、小米粉、红豆粉、α-亚麻酸、西兰花等原料。采用现代最先进工艺制成的健康食品或功能食品。
二、技术背景:本产品以藜麦粉(藜麦芽粉)、黑芝麻粉、小米粉、红豆粉、α-亚麻酸、西兰花等原料制成的一种新型产品。该产品含有全面的天然植物营养成分,具有滋阴养肾、健脾和胃、清虚热、养心安神、除湿利尿、通乳泌乳,可治孕产妇脾肾阴虚、消化不良、反胃呕吐、营养不良、腰膝酸软、产后气血不足、奶水稀少、贫血、口渴、食少纳呆、吃不下饭、修复体质。另外还具有增强免疫力、调节内分泌、促进儿童生长发育、健脑益智、促进脑细胞和视觉细胞发育、预防疾病、美容养颜、减肥、通便、延缓衰老、预防乳腺癌和子宫癌等功效,也是孕产妇的超级营养食品。目前市场上还没有同类产品,创新研发该产品可为给孕产妇、老人等特殊人群提供了一种新产品。该产品以优质纯天然药食两用全面营养植物成分制成的新产品,纯度高、生物活性强、吸收利用好、无任何毒副作用、服用方便、效果明显、特别适应用于孕产妇等特殊人群服用。
三、发明内容:孕产期是女性生命中一个特殊的生理时期,孕期所致的机体新陈代谢的变化使得机体对营养的需求大量增加。孕产期良好的营养状态,不仅是保证母体正常生理功能,也是胎儿正常发育,因此,全面均衡的营养对孕产妇的健康方面发挥非常重要的作用。如果缺乏全面均衡的营养,可能导致孕妇各种妊娠综合症患病危险增加,引发流产、畸胎、早产、死产、低出生体重量以及产后大出血等。孕妇和哺乳期营养缺乏,还会对胎儿及儿童今后的生长发育带来严重的不良影响。随着我国二孩的政策放开,每年约有3000多万妇女怀孕,同时约有2000多万孕妇分娩和哺育孩子,孕妇和乳母的营养与健康状况将直接影响到国家的人口素质和未来。因此,创新研发本产品。
四、原料配方:藜麦粉(藜麦芽粉)10-70千克、黑芝麻粉2-10千克、小米粉5-30千克、红豆粉10-40千克、α-亚麻酸0.5-1千克、西兰花1-8千克为原料。
五、技术主案:
(一)藜麦粉(Chenopodiumquinoawilld),又叫南美藜,奎麦,金谷子等。原产于美洲安第斯山区,是印加土著居民的主要传统食物,由于具有独特丰富全面的营养价值,养育了印加民族,被称为粮食之母,也可代替婴幼儿奶粉食用。近几年来引进我国青海等地区试种成功,在青藏高原海拔2500实以是柴达木盆地大面积种植。藜麦属藜木科双叶子藜麦的成熟种子。性平味甘,具有全面均衡补充营养,有增强机体功能和增强免疫功能,修复体质,提高机体适应能力、调节内分泌、促进儿童生长发育、健脑益智、预防疾病、美容养颜、减肥、通便、延缓衰老、防癌抗癌、降血压、降血脂、降血糖、防治心脑血管疾病、辅助治疗慢性疾病等功效,也是孕产妇的超级营养食品,被联合国粮农组织认为藜麦是唯一单体植物既满足人体基本营养需求的食物,推荐藜麦为最适宜人类完美的营养食品,并列为全球10大健康营养的“超级谷物”,“未来食品”,以促进人类的健康。尤其适应于高血压、高血脂、高血糖、心脑血管疾病,以及婴幼儿、孕产妇、儿童、老年人等特殊体质等人群,长期食用效果显著。
营养成分:藜麦含有丰富的蛋白质(高达20-26%,且营养品质高于奶粉和牛肉),碳水化合物、脂肪、多种氨基酸、其中含有人体必需的全部9种氨基酸,比例适当且易吸收,还富含不饱和脂肪酸、类黄酮、β-葡聚糖、胆碱、甜菜碱、α一亚麻酸、矿物质钙、镁、磷、钾、铁、锌、硒、锰、铜等,维生素B族、叶酸、维生素E等化合物,膳食纤维含量高达7.1%。
生理功能:1、增强免疫功能:研究发现,藜麦具有增强机体防病抗病能力,调节机体免疫功能的作用,其中藜麦中丰富的蛋白质是构成血红球和抗体的主要成分。实验证明,严重缺乏会使人的免疫细胞中的淋巴球大减,造成严重的免疫机能下降,且易感染疾病。另外,藜麦中含有β-葡萄糖对机体免疫系统有极强的作用,具有活化细胞的功能,防止机体被感染和修复被破坏的组织,同时,藜麦中β-葡萄糖还有激活细胞,提高免疫功能的作用。而藜麦中均衡的营养物质也可通过改善体质提高免疫力。
2、促进儿童生长发育:儿童生长发育的物质基础是各种已知的营养素,包括蛋白质、脂肪、碳水化合物、能量、维生素和有机盐等,它们不但决定着儿童生长发育的速度,也决定着生长发育的质量,长期的营养素不足,都会延缓儿童的生长发育,阻碍生理成熟,乃至发生因儿童营养不良所致矮小症。为保证儿童的生长发育,必须在日常生活中提供多种必需的营养素。因此要保证儿童良好的生长发育,就必须保证营养素齐全,数量充足,比例适当,以得到合理营养。据研究证明,藜麦是植物超级全营养,营养成分与牛奶和牛肉相当,在给非洲贫困地区的孩子每天吃适量的藜麦制品,2年后这些孩子的肌肉发育加快、身高增长、智力提高,在学校里更加活跃,喜欢说话和经常参加活动。因为藜麦能提供蛋白质、维生素、矿物质等营养素。因此,藜麦制品具有促进儿童生长发育功效。
3、孕产妇优质营养源:孕妇在怀孕期间对各类营养的需求是非常旺盛的,而藜麦的全营养特性和高含量正好可以为孕妇提供足够的营养。众所周知,机体的每一个细胞形成都需要蛋白质参与,在胎儿的整个生长过程中,需要更多的优质蛋白质供给。藜麦蛋白质含量高达16%-22%,并且是优质的完全蛋白质,品质和含量可以与脱脂奶粉及肉类媲美,是其它植物食物所不具备的。人体对蛋白质的吸收实际上是通过氨基酸完成的,其中有9种必需氨基酸是人体自身不能合成或合成速度不能满足人体需要,必须从食物中摄取的氨基酸。藜麦全部含有这9种必须氨基酸,而且比例非常,适宜人体吸收,尤其富含其他谷物中缺乏的赖氨酸。对于孕期反应严重,厌倦油腻和肉食,喜欢清淡素食的孕妇,藜麦绝对是最佳选择。
孕期对矿物质的需求较高。藜麦的矿物质含量几乎都高于常见粮食,其中锰的含量是最高的,在世界最健康的十种食品中,锰的含量评价是“极优”,1/4杯藜麦可以提供成人一天需求的50%锰。锰对再生系统非常重要,可保证胎儿的智力和骨骼发育正常。孕妇孕期还最易发生铁、锌、钙的缺乏。藜麦中丰富的铁是小麦的4倍,可防止孕期缺铁性贫血;藜麦富含锌元素(普通谷物中锌含量极微少),丰富的锌可防止胎儿发生中枢神经系统畸形和宫内发育迟缓、大脑发育受阻,还可帮助孕妇产后子宫恢复、防止产后出血;藜麦中丰富的钙是小麦的4倍,可帮助胎儿长出强壮的骨骼、健康的心脏、神经和肌肉。
藜麦特有的高膳食纤维和低糖特性,还可以帮助孕妇减少孕期易发生的便秘症状和患糖尿病的几率。
4、婴幼儿优质营养源:当宝宝降生后,妈妈的奶水质量对宝宝的成长至关重要,藜麦还可以提高产后母乳质量,应当多吃藜麦。宝宝开始吃辅食后,依然离不开藜麦。在原产地藜麦被用作奶粉的替代食品。藜麦易消化,口感好,可以给宝宝提供足够的优质蛋白质和各种必需微量元素、矿物质,增强抵抗力帮助宝宝健康成长。比如:镁不但帮助宝宝新陈代谢,还可阻止心血管组织对铅、镉等有害元素的吸收;欧米伽3对宝宝智力和视网膜发育起着决定性作用;藜麦不含麸质,可供刚开始吃辅食的宝宝和麸质过敏宝宝食用,还能减少小儿乳糜泻、婴儿湿疹和奶癣的发生。
5、减肥:多项研究表明,在摄入热量不变的前提下,饮食中增加藜麦制品的摄入量有助减肥。因为藜麦制品中含有丰富的钙和其他一些特殊的活性成分,能帮人体燃烧脂肪,减少脂肪堆积和控制体着有着重要的作用。藜麦制品有助于控制体重的另一因素可能与它含有丰富的蛋白质和膳食纤维能增加人的饱腹感对食欲控制有关,因为蛋白质和膳食纤维能产生较强的饱腹感,延缓胃排空,从而减少其他食物的摄入量来控制食欲,达到减肥的作用。
6、养颜美容:藜麦中含有丰富的蛋白、脂肪类黄酮,多种维生素和多种矿物质等活性成分容易被皮肤吸收,能促进新细胞生长,防止皮肤干燥和老化,使皮肤有光泽湿润,细腻,长期食用还可增加皮肤的活力和弹性,使皮肤变得清爽、润滑、洁白。研究证实,富含蛋白质食物具有补五脏、补虚损、强筋骨、滋润皮肤之功效。维生素和矿物质能使皮肤代谢胜利进行,减少雀斑,黄褐斑和老年斑的产生;脂肪酸具有保水润肤的作用;故均衡的营养能滋养肌肤,抗皱,延缓衰老,防止皮肤老化。
7、防癌抗癌:藜麦中含有多种活性物质,能有效破坏人体内的致癌危险自由基,并能迅速和细胞膜结合,使细胞处于防御致癌物质入浸的状态,因此具有防癌的作用。进一步研究发现,藜麦中的多种营养成份,能使机体内的细胞因子IL-2的含量增加,增强了T细胞和B细胞的功能,提高了NK细胞杀伤活性,使免疫器官的重量和对机体非特异性免疫功能增加的作用,从而达到有效抗癌的作用。
8、调节内分泌:研究表明,藜麦具有调节内分泌的作用。藜麦提取物能促进肾上腺皮质功能和增加肾上腺的重量,使血液中甲状腺素含量增加,因此,藜麦能调节内分泌。
此外,藜麦还具有延缓衰老、防治心脑血管疾病、护眼明目、通便、辅助治疗慢性疾病等作用。
(二)黑芝麻粉(Semensesaminigrum),为芝麻科植物的成熟种子。性平、味甘。归肝肾、大肠经。具有补肝肾、益精血、润肠等功效。适用于头晕眼花,耳鸣耳聋,须发早白、病后脱发、肠燥便秘等。现代药理研究认为,黑芝麻具有保护视力、改善视疲劳、保护肝脏、增强免疫力、美容养颜、祛除黄褐斑、抗氧化、延缓衰老、改善记忆力、降血脂、降血压等作用。
化学成分:蛋白质、脂肪酸、芝麻素,花色苷、胡麻甙、矿物质、多种维生素、膳食纤维等成分。
药理作用:1、提高女性生育能力:黑芝麻丰富维生素E,除了具有良好的抗氧化作用外,还对人体生理机能有良好的促进作用,对于女性能够使雌激素浓度提高,因此,维生素E又称为“生育酚”。另外黑芝麻含有丰富的蛋白质、维生素、矿物质等成分,还有提高女性生育能力的作用。
2、补钙:黑芝麻每百克含有800多毫克钙,是牛奶的4倍,钙是人体必需的营养素。尤其是孕妇、乳母、婴幼儿、青少年和老年人更需要补钙。研究认为,如女性在怀孕时期,胎儿急速发育,从母体内吸收大量的钙以助骨骼的发育生长,因此,女性在怀孕前期和孕期就因加强体内钙的储存,以保证胎儿在母体很好发育。一但孕妇血钙过低就可能动用储存全身的骨钙,会导致孕妇在妊娠中期出现肌肉痉孪、腰腿酸痛、骨关节疼痛、水肿等现象,严重时会导致骨质疏松、牙齿松动及产乳汁不足等。所以因保持饮食中摄取充足的钙,既可降低新生儿患病风险,使宝宝具有健康体魄,又能保证准妈妈的健康。另外,钙还是参与神经递质的释放和神经冲动的传导,具有安静情绪的作用,如钙不足性情暴躁,抗病能力下降,胎儿智力发育迟缓,容易出现疲劳和注意力分散等。因此,女性在孕期一定要保证充足钙。
3、促进胎儿视力、大脑发育:黑芝麻含有丰富不饱和脂肪酸,女性在怀孕期间不饱和脂肪的摄入极为重要,因为不饱和脂肪酸对胎儿的视网膜、大脑等组织功能健全十分重要,长期缺乏不饱和脂肪酸会影响注意力和认知发育。从胎儿期26周至出生至两岁是体脑部和视网膜发育最为重要阶段,由于母体是胎儿和婴幼儿营养的主要提供者,所以孕期和哺乳期准妈妈要特别注意不饱和脂肪酸的摄入。黑芝麻中含有丰富的不饱和脂肪酸、磷脂、叶酸、维生素A、维生素D、维生素E等营养物质。孕妇和哺乳期多吃一些黑芝麻。
4、抗视疲劳:黑芝麻含有丰富的矿物质和多种维生素等成分,对电脑工作人员及长时看电视、玩游戏和手机产生的视疲劳具有一定的缓解作用。
5、护肝:动物实验证明,黑芝麻可以保护肝脏的作用。黑芝麻中含有大量的不饱和脂肪酸和丰富的维生素E,能降低血脂和甘油三酯,消除肝脏内的脂肪,对慢性肝炎和脂肪肝有一定的治疗作用据报道,一项研究证实,黑芝麻中含有的“芝麻素”能抑制前期肝癌病变。动物实验发现,前期癌症面积、癌发素的抑制率比对照组在癌形成初期,生长期及整个患癌期分别达40%、49%、53%以上。并且老鼠的体重和肝脏重量均有变化,说明芝麻素抑癌的效果非常明显。
6、养颜润肤:研究认为,减少自由基的产生,清除老化代谢产物和提高抗氧化酶活性等,是延缓皮肤衰老的最有效措施,黑芝麻中含有丰富的天然维生素E、维生素E是强抗氧化剂,可以起到养颜润肤的作用。另外,芝麻是四大油料作物之一,而芝麻油中大多数营养成分是不饱和脂肪酸,亚油酸就约占50%。而亚油酸具有很好养颜美容作用,如果人体缺乏亚油酸时,就容易引起皮肤干燥、鳞屑肥厚,皮肤生长迟缓和血管中胆固醇沉积等症状,因此,亚油酸又有“美肤、养颜、润肤”之称。
7、乌发靓发:现代研究证明,头发毛囊中黑素细胞分泌黑色素,减少白发的主要原,其中酪氨酸酶数量减少是病理机制之一,研究发现,黑芝麻提取物能促进酪氨酸酶增加,提高黑色素的含量,因此,黑芝麻具有显著的乌发靓发作用。
8、延缓衰老:研究表明,黑芝麻中含有丰富的防病抗衰活性物质,如维生素E、亚油酸、花生酸、芝麻素、不饱和脂肪酸等成分。动物实验表明,黑芝麻可降低肝脏和机体脂褐质水平,提高血浆中抗氧化剂含量,从而延缓衰老现象的发生。
9、润肠通便:黑芝麻含有的多种营养成分,能起到润滑肠道的作用,因此,黑芝麻具有润肠通便的作用。
另外,黑芝麻还具有降血压、防治心血管病、促进新陈代谢、改善血液循环、增强细胞活力等作用。
(三)小米粉(Millet),又叫粟米、谷子等,为禾科植物一年生植物粟的子实,因子实小而故名。小米性温、味甘咸。具有滋阴养肾、健脾和胃、清虚热、除湿、利小便等功能。《本草纲目》云,小米“有养心安神之效”,可治脾虚气弱、消化不良、反胃呕吐、消渴烦热、腰膝酸软、泻痢等症。民间常用小米煮粥,加红糖食用,可治产后口渴、内空。用小米山药共研细未,煮糊加白糖适量辅喂婴儿,可治小儿消化不良,因脾胃虚弱引起的腹泻。《太平圣经》方将小米同羊肉一起煮,加入调味品煮至粥,空腹食用治疗产后气血不足、食少纳呆。《圣济总录》用粟酥粥治小便不通。《寿亲养老新书》用小米粥调入面粉煮食空腹服用,治疗老人和产妇脾胃虚弱、呕吐、吃不下等症。现代营养化学和药理研究表明,小米含有很高的营养成分,对老人、孕妇、产妇、婴幼儿具有营养保健功能,被称之为“保健米”是养生的首选食品。生病后,孕妇、产后以及体质虚弱者都可服用,小米不仅有滋阴补血、养胃的功能,还能助眠安神,对缓解压力紧张也一定的作用,一年四季均可服用。
化学成分:小米含有丰富的蛋白质、碳水化合物、脂肪十多种氨基酸(其中人体必需的8种氨基酸),且消化吸收高、维生素B1、维生素B2、硫胺素、维生素A、维生素E、钙、磷、铁等成分。
生理功能:1、健脾助消化:长期患有脾胃方面病症的人,经常喝小米粥可调理各种不同原因所致的肠胃病症,帮助其消化,防止消化不良。
2、补肾:五谷都具有养精气、补肾气的作用,而五谷中小米补肾效果最强。
3、养心安神:小米中富含色氨酸,而这种氨基酸有调节睡眠功效,经常失眠的中老年等人群可在睡前适量喝一些小米粥,有助于睡眠的作用。
4、祛斑美容:研究表明,小米具有减轻皱纹、祛除色斑、减少色素沉着的功效。
5、减少细菌滋生:研究显示,多吃小米能够减少口中细菌滋生,去除口臭。
(四)红豆粉(Phaseoli),红豆为一年生豆科植物,红豆或赤豆的干燥成熟种子,性平、味甘。具有清热解毒、利水除湿、活血排脓、通乳泌乳等功效。可治丹毒、水肿脚气、乳腺炎、乳汁不通、产生恶露不净、肠风下血等症。由于红豆具有生津液、利小便、消肿胀、止呕吐之功,被明代著名药物学家李时珍称为“心之谷“。现代医学研究,红豆具有增强免疫力、保护肝脏、改善贫血、降血脂、减肥、降血糖、祛除痤疮和黄褐斑、防辐射等功效。
营养成分:红豆含丰富的蛋白质、脂肪、碳水化合物、膳食纤维、钙、磷、铁、维生素B1、维生素B2、尼古酸等。
药理作用:1、增强免疫力:研究显示,红豆具有很好的增强免疫力的作用。体外试验证实,红豆能促进E玫瑰花结反应,形成率为48.25%,对淋巴细胞增殖反应有一定刺激作用。因此,红豆有增强免疫力的作用。
2、抗菌:研究表明,红豆煎剂对金黄色葡萄球菌,痢疾杆菌和伤寒杆菌具有显著的抑制作用。
3、清热解毒:中医认为红豆具有清热解毒的作用,能消散热毒所致痈疡肿块,促进脓液排出。李时珍《神农本草经》中记载,红豆能“消热毒痈肿、散恶血不尽、烦满、治水肿胀等”。
4、利水消肿:现代医学研究发现,红豆中含有的一种皂甙物质,能促进通便和排尿,对心脏肾病引起的水肿,有辅助治疗作用。同时,红豆含有的其他成分有利血、利尿、消肿、促进心脏活化功能、长期服用能够减轻肾脏的病理变化。
5、促进造血和改善贫血:研究认为,红豆含有丰富铁元素,铁是合成血红蛋白原料,能促进人体造血系统,改善缺铁性贫血。孕妇在孕期对各种营养需求都会增加,尤其是铁为了维持孕妇自身的铁需要外,还要为胎儿生长提供铁。如果孕妇发生缺铁性贫血,对胎儿影响很大,如导致胎儿宫内发育迟缓、低出生体重、早产、死产、新生儿死亡等。此外,孕妇缺铁还会影响胎儿免疫系统和智力发育以及出生后智力行为的发育等。
6、减肥:红豆有良好的减肥瘦身效果,尤其是瘦腰腿。陈士良在《食性本草》里记载,红豆“久食瘦人”,证明红豆对肥胖症有一定的疗效。现代医学研究发现,食用红豆具有很好的减肥瘦身效果,而瘦身的部位主要是腰部大腿。
7、排毒养颜:随着我国的快速发展,人们的生活节奏加快,生活、工作压力大,脸上往往会出现这样或那样的问题,如黄褐班、雀斑、老化、浮肿等症,红豆有良好的利水解毒作用,可以消除面部黄褐斑、青春痘和痤疮等症。研究认为,红豆还是一种很好药食两用养生保健佳品,尤其对女人,红豆含有丰富的膳食纤维,有很好的润肠通便作用,具有排毒养颜功效。
此外,红豆还具有保护肝脏、改善缺铁性贫血、通乳泌乳、降血脂、降血糖、防辐射等作用。
(五)、α-亚麻酸(a-LinolenicacidALA),是DHA和EPA的母体,主要存在于亚麻籽油,紫苏籽油之中,在人体内可转化为DHA、DPA、EPA、抗凝酶等活性物质,α-亚麻酸属于ω-3系列多烯脂肪酸,为不饱和脂防酸,是构成人体组织细胞的主要成分之一,在人体内不能合成、代谢,为必需脂肪酸必需从体外摄取。现代药理研究认为,α-亚麻酸能增强智力和免疫力、保护视力、降血脂、降血压、降血糖、抑制出血性脑疾病和血栓性疾病,抑制癌症的发生与转移,预防心肌梗塞和过敏性疾病,炎症以及减缓人体衰老等。另外,α-亚麻酸还可预防和治疗糖尿病、类风湿病、抑郁症、精神分裂症、老年痴呆症、过敏、哮喘、肾病和慢性阻塞性肺炎等。
生理功能:1、增强免疫功能:α-亚麻酸有助于强化免疫系统,在人体免疫系统中必需脂肪酸,能保护基因免受损害,对增强人体免疫力,提高人体抵抗力具有重要的作用。有研究发现,α-亚麻酸可影响细胞膜结构的完整性、稳定性和流动性,影响细胞运动,受体形成,受腰带与配体的结合等,从而减少细胞因子的产生和释放,改善肺、肝脏、肠的血供和氧代谢。因此,α-亚麻酸在细胞水平诱导的改变较为持久,是有效的免疫调节营养素。
2、增进胎儿大脑神经和视神经发育:α-亚麻酸是一种多不饱和脂肪属n-3系,是神经细胞合成的最基础的原料之一,它的衍生产物是二十二碳六烯酸DHA和二十碳五烯酸EPA。以α-亚麻酸在孕期的作用为例,由于DHA是大脑、神经和视觉细胞中重要的脂肪酸成分,所以对胎宝宝的器官发育、生理功能的正常发挥以及多种疾病的防治有着重要的作用;EPA是神经信号传递过程中必不可少的物质,当化学及电子信号通过脑细胞膜时,脑细胞要释放由EPA派生的信号分子,所以为了使大脑功能完美,就需要更多的EPA,去填补消耗。国外调查资料显示,孕期补充了足量的α-亚麻酸,可以使宝宝的智商平均提高20%-30%。通过大量的基础研究、流行病学调查、动物试验及临床观察表明,α-亚麻酸对于人体的生理功效是多方面的,对于孕产妇来讲有16个作用,其中最重要的是:控制基因表达、优化遗传基因、转运细胞物质原料、控制养分进入细胞,影响胎婴儿脑细胞的生长发育。其中对于大离发育尤为突出。但由于α-亚麻酸不能自身合成,是准妈妈最缺乏的营养素。胎宝宝大脑发育的好坏决定了宝宝今后的智力水平。人类的大脑发育分为三个阶段:第一阶段是细胞增殖阶段。这一阶段是指妊娠3-6个月,这是脑细胞生长的第一个高峰期,宝宝能否长成优秀的大脑需要1000亿个脑神经细胞构成,这个阶段是决定脑细胞数量的重要阶段。第二个阶段是脑细胞增殖和增肥阶段。这一阶段是指妊娠7-9个月,是脑细胞增殖和增肥的时期,一方面脑细胞数量持续增加,另一方面脑细胞体积开始增大,细胞和细胞之间的突触接合,大脑的信息网络形成。第三个阶段是脑细胞持续增肥阶段。这一阶段是指0-6月龄宝宝的大脑发育,此时是脑细胞增大的又一个高峰期,在此阶段,脑细胞持续不断地增大。而α-亚麻酸正是促进脑细胞增殖和增肥的营养元素,从大脑发育的阶段性可以看出,宝宝出生以后,脑细胞的数量就不再增加了,从这方面来讲孕期补充α-亚麻酸的意义大于产后补充。科学家在大量的试验中研究证实:α-亚麻酸的代谢物占孩子脑重量的60%以上,占组成成分的30%。α-亚麻酸的代谢物DHA是大脑细胞的重要物质成分,是构成脑磷脂、脑细胞膜的物质原料,对大脑细胞的分裂、增殖、神经传导、突触的生长和发育起着极为重要的作用。对孩子的视觉、大脑活动、脂肪代谢、胎儿生长及免疫功能都有极大影响。孕妇摄入α-亚麻酸后,运用脂肪代谢出DHA,其代谢特点是胎宝宝需要多少,孕妇代谢多少,相比直接补充DHA的优势是适量,直接补充DHA对于“量”的间题很难控制。孕妇通过血液将DHA输送到胎盘供应胎儿,孕妇体内α-亚麻酸充足,出生儿的思维速度比缺乏者的出生儿能快150倍,注意力、记忆力能高出5--10倍。如果孕产妇体内缺乏α-亚麻酸,就会使胎儿产生“脑饥饿”。“脑饥饿”的胎儿在出生前脑细胞就长不够数量,并且质量低劣、智力受损、同时还有机体发育缓慢、视力不好等症状。
此外,α-亚麻酸属脂类营养元素,是不饱和脂肪酸,它能通过和饱和脂肪酸的相互调节,来调控孕妇和胎儿的体重,这一点在许多孕妇的临床资料中得到充分地证实。因此,α-亚麻酸对孕妇和胎儿都具有重要的作用。
3、减肥:α-亚麻酸能促进能量产生,使人体获得更多的氧气,有助于增加氧气比率、代谢率、能量水平及体力。有助于减轻体重,α-亚麻酸在人体会增加代谢率及能量消耗,燃烧更多的卡路里,能对脂肪细胞产生一定的作用,使其转化为像荷尔蒙同样的前列腺素,这种物质能让人保持苗条。另外,α-亚麻酸有助于人体排出存在于肾脏内多余水分,而这些水分是某些人体超重的重要因素。α-亚麻酸减肥:据报道,α-亚麻酸还具有抑制肥胖的作用,它能阻止纤维素细胞和脂肪细胞分化,可防止脂肪细胞数量增多型儿童肥胖,因此,儿童多食用含α-亚麻酸丰富的食品,以帮助更好的减肥。
4、抗炎:α-亚麻酸对各种炎症和细胞因子有抑制作用,能减少炎症因子的生成。另有报道,α-亚麻酸具有良好的抗炎作用,有实验发现,风湿性关节炎患者摄入α-亚麻酸后可以完全停止服用非类固醇抗炎药物。另有部分可将非固醇抗炎药物减半。
5、延缓衰老:据报道,美国研究人员发现,ω-3脂肪酸能延缓人体衰老的进程。成年人服用ω-3脂肪酸有助于改善体脂肪比例,在一定程度上对“端粒”(染色体、端粒位上的丝点,其主要功能是保持基因的稳定状态)有益,人体中的脂肪比例越低端粒就越长,对健康越有益。研究还发现,ω-3脂肪酸能将血液中的自由基对人体造成的损害降低15%,另外,ω-3脂肪酸还能降低人体内白细胞介素6的含量和人体内炎症水平。
(六)西兰花(broccoli),又名椰花菜,为十字花科一年生植物。性平、味甘,入肾、脾、胃经。具有补肾填精、健脑壮骨,补脾和胃;主治久病体虚、肢体痿软、耳鸣健忘、脾胃虚弱等症。
化学成份:主要含蛋白质、脂肪、膳食纤维、硫葡萄糖苷、吲哚类、类黄酮、矿物质、维生素、类胡萝卜素等。
生理功效:1、促进胎儿正常生长发育:西兰花含有丰富的叶酸,叶酸对人体细胞生长及核酸、氨基酸、蛋白质的合成均具有重要的作用,也是胎儿生长发育不可缺少的营养素。叶酸可用于治疗叶酸缺乏所致的巨幼红细胞贫血和降低细胞管畸形及唇裂胎儿出生率的预防给药。叶酸还是细胞增长不可缺少的物质,还能促进乳汁的分泌。如果孕妇缺乏叶酸,可增加胎儿发育迟缓,发生神经管畸形及早产的危险。因此,叶酸的补充对于孕妇极为重要。另外叶酸是胎儿发育所不可缺少的营养素,备孕妈妈提前补充叶酸,能起到预防孕妇贫血的作用,同时也能减少孕晚期患先兆子痫的发生。另外,服用叶酸能降低宝宝发生先天性疾病的概率。
2、预防乳腺癌和子宫癌:据报道,西兰花具有显著的防癌抗癌功效。西兰花含有不少抗癌物质,如吲哚-3-甲醇、3,3-二吲哚甲烷、萝卜硫素对乳腺癌和宫颈癌等具有较好的防治作用。吲哚类化合物对多种致癌物质既有解素酶的催化剂之外,也具有保护DNA组织的作用。此外,还能提高有防护作用的雌激素代谢物的比例,有效降低雌激素水平,可有效防治乳腺癌和子宫癌。
3、增强免疫功能:西兰花含有丰富的维生素C,具有增强人体免疫功能。促进肝脏解毒能力,增强体质,增加抗病能力。
4、护肤美容、西兰花含有丰富的维生素A、维生素C和胡萝卡素,能增强皮肤的抗损伤能力,有助于保护皮肤的弹性。西兰花还有助于维持皮肤的细胞组织正常机能,减少皮肤皱纹,刺激皮肤新陈代谢,保持皮肤润泽细腻。
综上所述:该产品含有天然植物全面的营养成分,具有滋阴养肾、健脾和胃、清虚热、养心安神、除湿利尿、通乳泌乳,可治孕产妇脾肾阴虚、消化不良、反胃呕吐、营养不良、腰膝酸软、产后气血不足、奶水稀少、贫血、口渴、食少纳呆、吃不下饭、修复体质。另外还具有增强免疫力、调节内分泌、促进儿童生长发育、预防疾病、美容养颜、减肥、通便、延缓衰老、预防乳腺癌和子宫癌等功效,也是孕产妇的超级营养食品
六、制作工艺:1、调配混合:将配方中的所有原料按物理特性进行混合。
2、搅拌:将混合好的原料充分搅拌均匀。
3、检验包装:将搅拌均匀的原料,检验合格包装成为正式产品。
调配混合是将配方中的原料按物理特性进行混合工序。搅拌是将混合好的原料充分搅拌均匀的工序。检验包装是将搅拌均匀的原料检验合格包装成为正式产品。
七、质量标准:
1、理化指标:
2、服用量:每日3次,每次1包(50克)
3、适宜人群:适应于孕产妇等特殊人群。
八、具体实施方式:
实施例:取藜麦粉(藜麦芽粉)10-70千克、黑芝麻粉2-10千克、小米粉5-30千克、红豆粉10-40千克、α-亚麻酸0.5-1千克、西兰花1-8千克为原料,经过将以上原料混合,充分搅拌均匀,送入包装机按设计用量包装成为小袋,检验合格,包装为成品。
Claims (1)
1.藜麦孕产妇超级营养粉制作工艺,其特征为:藜麦粉(藜麦芽粉)10-70千克、黑芝麻粉2-10千克、小米粉5-30千克、红豆粉10-40千克、α-亚麻酸0.5-1千克、西兰花1-8千克为原料,经过将以上原料混合,充分搅拌均匀,送入包装机按没汁用量包装为小袋,检验合格,包装为成品。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610180050.1A CN105707707A (zh) | 2016-03-28 | 2016-03-28 | 藜麦孕产妇超级营养粉 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610180050.1A CN105707707A (zh) | 2016-03-28 | 2016-03-28 | 藜麦孕产妇超级营养粉 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105707707A true CN105707707A (zh) | 2016-06-29 |
Family
ID=56158379
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610180050.1A Pending CN105707707A (zh) | 2016-03-28 | 2016-03-28 | 藜麦孕产妇超级营养粉 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105707707A (zh) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106819798A (zh) * | 2016-12-27 | 2017-06-13 | 青海三江沃土生态农业科技有限公司 | 一种藜麦面粉的加工方法 |
CN106858569A (zh) * | 2017-01-06 | 2017-06-20 | 北京农品堂食品有限公司 | 一种孕产期不同阶段食用的藜麦植物能量棒及其制备方法 |
CN107549634A (zh) * | 2017-09-04 | 2018-01-09 | 北京水木源生物科技有限公司 | 一种孕期营养粉及其制备方法 |
CN107712577A (zh) * | 2017-09-04 | 2018-02-23 | 北京水木源生物科技有限公司 | 一种备孕期女士营养粉及其制备方法 |
CN107751795A (zh) * | 2017-09-04 | 2018-03-06 | 北京水木源生物科技有限公司 | 一种备孕期男士营养粉及其制备方法 |
CN107751796A (zh) * | 2017-09-04 | 2018-03-06 | 北京水木源生物科技有限公司 | 一种哺乳期营养粉及其制备方法 |
CN110771869A (zh) * | 2019-09-29 | 2020-02-11 | 亨美久健康科技(广东)有限公司 | 孕妇第三阶段全营养早餐及其制备方法 |
CN111280443A (zh) * | 2020-03-24 | 2020-06-16 | 浙江劢康生物科技有限公司 | 一种具有调脂减肥的保健食品及其制备方法 |
CN111480837A (zh) * | 2020-05-26 | 2020-08-04 | 辽宁康汇医学临床研究有限公司 | 一种孕妇用营养组合物、制备方法及其应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104473026A (zh) * | 2014-12-25 | 2015-04-01 | 周连平 | 高血压、高血脂患者专用营养粉 |
CN105211718A (zh) * | 2015-10-24 | 2016-01-06 | 崔子扬 | 一种孕妇用藜麦营养粉及其制备方法 |
-
2016
- 2016-03-28 CN CN201610180050.1A patent/CN105707707A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104473026A (zh) * | 2014-12-25 | 2015-04-01 | 周连平 | 高血压、高血脂患者专用营养粉 |
CN105211718A (zh) * | 2015-10-24 | 2016-01-06 | 崔子扬 | 一种孕妇用藜麦营养粉及其制备方法 |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106819798A (zh) * | 2016-12-27 | 2017-06-13 | 青海三江沃土生态农业科技有限公司 | 一种藜麦面粉的加工方法 |
CN106858569A (zh) * | 2017-01-06 | 2017-06-20 | 北京农品堂食品有限公司 | 一种孕产期不同阶段食用的藜麦植物能量棒及其制备方法 |
CN107549634A (zh) * | 2017-09-04 | 2018-01-09 | 北京水木源生物科技有限公司 | 一种孕期营养粉及其制备方法 |
CN107712577A (zh) * | 2017-09-04 | 2018-02-23 | 北京水木源生物科技有限公司 | 一种备孕期女士营养粉及其制备方法 |
CN107751795A (zh) * | 2017-09-04 | 2018-03-06 | 北京水木源生物科技有限公司 | 一种备孕期男士营养粉及其制备方法 |
CN107751796A (zh) * | 2017-09-04 | 2018-03-06 | 北京水木源生物科技有限公司 | 一种哺乳期营养粉及其制备方法 |
CN110771869A (zh) * | 2019-09-29 | 2020-02-11 | 亨美久健康科技(广东)有限公司 | 孕妇第三阶段全营养早餐及其制备方法 |
CN111280443A (zh) * | 2020-03-24 | 2020-06-16 | 浙江劢康生物科技有限公司 | 一种具有调脂减肥的保健食品及其制备方法 |
CN111480837A (zh) * | 2020-05-26 | 2020-08-04 | 辽宁康汇医学临床研究有限公司 | 一种孕妇用营养组合物、制备方法及其应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105707707A (zh) | 藜麦孕产妇超级营养粉 | |
CN101473953B (zh) | 净血排毒组合食品及其加工方法和应用 | |
CN108142803A (zh) | 全营养粗粮 | |
US20190335796A1 (en) | Optimized nutrient food | |
Ahuja et al. | Rice–a nutraceutical | |
CN106107463A (zh) | 超级藜麦抗疲劳奶茶制作工艺 | |
CN105815514A (zh) | 藜麦减肥奶茶 | |
CN106418501A (zh) | 一种具有减肥功能的保健食品 | |
CN104921133A (zh) | 一种女性谷菜果营养食品及其制备方法 | |
CN106578139A (zh) | 一种健脑菜籽油及其应用 | |
CN110038098A (zh) | 一种菊蒲清风茶及其制备方法 | |
CN105994748A (zh) | 老青海青稞酥油茶 | |
CN104323391A (zh) | 一种植物保健固体饮料及其制备方法 | |
CN102511858A (zh) | 一种适合孕妇食用的红枣浓浆及其生产工艺 | |
CN104783174A (zh) | 一种纯天然营养免疫保健固体饮料的配制方法 | |
CN106173822A (zh) | 高级人参果孕妇月子营养粉 | |
CN103798596B (zh) | 一种供心脑血管疾病患者食用的全营养配方食品 | |
CN102511882A (zh) | 一种有助于改善生长发育的红枣浓浆 | |
CN106035686A (zh) | 超级藜麦养生植物奶 | |
Amudha et al. | Rice-a novel food with medicinal value | |
CN104187264B (zh) | 一种提高人体免疫力的营养组合物及其制备方法 | |
CN104223201A (zh) | 一种浒苔八宝粥 | |
CN108378377A (zh) | 宫颈癌全营养配方食品的制备方法及其应用 | |
CN107259530A (zh) | 一种用于安神、改善睡眠的百香果配方食品 | |
CN107752011A (zh) | 一种食品组合物及其用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160629 |